N-acetyl-r-leucyl-r-leucyl-t-norleucinal, (LLnL), which inhibits proteasomes in addition to other proteases, was found to prolong the association of major histocompatibility complex class I molecules with the transporters associated with antigen processing (TAP), and to slow their transport out of the endoplasmic reticulum (ER). LLnL induced a reversible accumulation of ubiquitinated proteins and changed the spectrum ofpeptides bound by class I molecules. These effects can probably be attributed to proteasome inhibition. Unexpectedly, in the TAP=deft= cient cell line. 174, the rate of intracellular transport of human histocompatibility leukocyte antigen (HLA) A2 was also reduced by LLnL, and the generation of most HLA-A2-associated signal sequence peptides was inhibited. The inhibition of HLA-A2 transport in .174 cells was found to be less sensitive to LLnL than in wild-type cells, and a similar difference was found for a second protease inhibitor, benzyloxycarbonyl-r-leucyl-r-leucyl-t-phenylalanilal. These data suggest that under some conditions such inhibitors can block trimming of peptides by an ER peptidase in addition to inhibiting cytosofic peptide generation.
N
'ewly synthesized MHC class I heavy chain [~2-microglobulin ([~2m) 1 dimers bind peptides in the endoplasmic reticulum (ER) before their transport to the cell surface. The vast majority of the associated peptides are derived from cytosolic proteins. These peptides are transported into the ER from the cytosol in an ATP-dependent fashion by'the transporters associated with antigen processing (TAP; for a review see reference 1), which physically associate with peptidefree class I-[32m dimers via the TAP. 1 subunit (2-4). Peptide binding to the class I molecules triggers their release from TAP, allowing their transport to the cell surface. Certain MHC class I alleles also bind peptides derived from the signal sequences of a small number of secreted or type I transmembrane proteins (5) (6) (7) . In these cases, peptide loading is usually, though not always (8) , independent of TAP.
The predominant protease responsible for the generation of cytosolically derived, TAP-dependent, class I-associated 1Abbreviations used in thispaper: 132rn, 132-microglobufin; endo H, endoglycosidase H; ER, endoplasmic reticulum; 1P-30, the 'y interferon inductible protein; LLnL, N-acetyl-t-leucyl-t-leucyl-t-norleucinal; RP, reverse phase; TAP, transporter associated with antigen processing; TBS, Trisbuffered saline; Z-LLF-CHO, benzyloxycarbonyl-tqeucyl-r-leucyl-rphenylalanilal.
peptides is thought to be the proteasome, a large (20S) multisubunit protease. The 20S proteasome can degrade proteins in vitro, but in vivo it predominantly exists as the nucleus of a larger (26S) ATP-dependent complex (9, 10) . The 26S proteasome is responsible for the degradation of ubiquitinated proteins as well as at least one nonubiquitinated protein, omithine decarboxylase (11, 12) . Two subunits of the proteasome, LMP2 and LMP7, are encoded in the MHC (13) . Mice with targeted disruption of either of these genes exhibit some deficiency in CTL development, and LMP7-deficient mice exhibit a reduction in expression of class I MHC molecules (14, 15) . Additionally, treatment of antigen-loaded target cells with proteasome inhibitors prevents their recognition by class I-restricted CTL (16) . It has also been argued that ubiquitination of cytosolic protein antigens is important for their recognition by CTL, because mutant cell lines temperature sensitive for a key step in ubiquitination exhibit reduced sensitivity to CTL (17) , although this finding is not universally accepted (18) .
One of the inhibitors used by Rock et al. (16) to implicate the proteasome in MHC class I peptide generation in living cells was the peptide aldehyde N-acetyl-L-leucylr-leucyl-r-norleucinal (LLnL), which has recently been shown to bind to the active sites of the archebacterial proteasome (19) . The mammalian proteasome has been shown to have at least five different proteolytic activities, and LLnL inhibits them to varying degrees (20, 21) . In this study, we set out to examine the effects of proteasome inhibition on TAP-class I association and on the rate of egress of class I-peptide complexes from the ER. In addition to finding anticipated effects, we made the surprising observation that transport of HLA-A2 molecules in TAPnegative cells was slowed by LLnL, and by a second proteasome inhibitor, benzyloxycarbonyl-t-leucyl-L-leucyl-t-phenylalanilal (Z-LLF-CHO), and found that the profile of associated signal sequence peptides was also affected by LLnL. The implication of these findings for potential ER processing of class I-associated peptides is discussed,
Materials and Methods
Cell Lines. Transfectants of the HMY2.CIR cell line, C1R.A2, C1R.BT, and CIR.B27 and the TAP-negative mutant cell line .174 have been previously described (22, 23) . All cell lines were maintained in IMDM (GIBCO BRL, Gaithersburg, MD) with 5% calf serum (Hyclone Laboratories Inc., Logan, UT) and gentamicin at 20 p~g/ml.
Antibodies. The mAbs 4E (anti-HLA-B locus), BB7.2 (anti-
HLA-A2), and 1G12 (antitransferrin receptor) were previously described (24) (25) (26) . Affinity-purified anti-TAP.1 rabbit serum R.RING4C generated against a COOH-terminal peptide from TAP.l, (2) , and the rat mAb 3B10.7 (anti-class 2) were also previously described (27 (28) . To detect TAP-associated class I molecules in R.RING4C immunoprecipitates from digitonin extracts, the protein A beads were heated at 100~ for 5 rain in 2% SDS, 2 mM dithiothreitol in TBS, diluted 10-fold in 1% Triton )(-100 in TBS with 10 mM IAA, and allowed to incubate at room temperature for 30 rain. After cooling to 4~ released class I heavy chains were precipitated as above with 3B10.7 and protein G-Sepharose.
Immunoblots. Blots were performed as described (29 ) was added to both cell solutions and incubated for 5.5 h at 37~ Cells were washed with PBS and class I-associated peptides were isolated as previously described (6) . Briefly, pellets were lysed at 107 cells/ml in 2% polyoxyethylene lauryl ether (Sigma Chemical Co.) in 10 mM Tris, 50 mM NaC1, pH 7.4, with PMSF, TLCK, and IAA. The postnuclear supernatants were cleared by centrifugation for I h at 100,000 g and applied to affinity columns. Affinity columns were packed with Biogel A15m beads (Bio-Rad Laboratories, Hercules, CA) coupled to the mAbs 4E or MA2.1. Bound class I molecules were eluted and denatured by adding 10% acetic acid, and low molecular weight species were separated from class I heavy chain and ~2m by filtering through a Centricon 10 (Amicon, Beverly, MA). Filtrates were resolved on a reversed-phase (RP) column (p~Bondapak C18) using a HPLC system (Waters Chromatography Division, Milford, MA). Gradients were generated using an increasing concentration of acetonitrile in 0.1% hydrochloric acid. Flow was 0.5 ml/min and 1. uitinated proteins are targeted for degradation by the 26S protease complex, resulting in free ubiquitin and peptide fragments (11) . To confirm that inhibition of the core 20S proteasome of this complex by LLnL disrupts the degradation of ubiquitinated proteins, cell lysates of LLnL-treated cells were subjected to SDS-PAGE, electrophoreticaUy transferred to an Immobilon membrane, and probed with an anti-ubiquitin serum ( Fig. 1) . In control cells, the major bands were found at ~8 and 14 kD, most likely representing ubiquitin and di-ubiquitin, respectively. However, when cells were treated with LLnL, the majority of the anti-ubiquitin-reactive species migrated in the high molecular weight region, between 97 and 300 kD ( Fig. 1 , center lane). The species between 97 and 300 kD presumably represent a mixture ofubiquitinated proteins normally degraded by the 26S protease complex (32) . The accumulation of ubiquitihated proteins was shown to be reversible. Cells washed free of LLnL and then incubated at 37~ for an additional hour (Fig. t , right lane) exhibited a decrease in high molecular weight bands. Enhancement of the low molecular weight bands represents a large pool of newly freed ubiquitin and di-ubiquitin induced by LLnL. These results are consistent with the suggestion that a major target of LLnL is the proteasome.
LLnL Treatment Slows the Egress of MHC Class I Complexes from the ER.
Inhibition of peptide generation by the proteasome would be expected to reduce M H C class I peptide loading, and consequently, delay class I transport. To examine this, CllL.A2, CllL.B7, and C1R.B27 cells were incubated in the presence or absence of 250 IxM LLnL for 1 h at 37~ In the continued presence or absence of inhibitor, the cells were pulse labeled with [35S]methionine, chased for various times, and extracted in detergent. Class I molecules were immunoprecipitated with the conformation-specific antibodies BB7.2 (anti-HLA-A2) or 4E (anti-HLA-B). After treatment with or without endo H the immunoprecipitates were subjected to SDS-PAGE and the ratio of the endo H-resistant to endo H-sensitive class I molecules was quantitated (Fig. 2, A-C) . Fig. 2 A shows that almost all of the HLA-A2 molecules had become resistant to endo H by 120 rain in control cells. However, in the presence of LLnL, the rate of acquisition of endo H resistance was reduced. The amount of precipitable HLA-A2 was also decreased in cells treated with LLnL, as seen by the decreased band intensity. Both of these findings are consistent with a reduction in class 1-associated peptides. HLA-A2 cannot leave the EIL until peptide has bound, and the amount of stable, properly assembled class I molecules is decreased. Similar results were found with HLA-B7 and HLA-B27 (Fig. 2, B and C) .
As a specificity control, a pulse-chase analysis of a nonpeptide-dependent molecule, the transferrin receptor, was performed (Fig. 2 D) . The transferrin receptor is a dimer of a 90-kD protein with three N-linked glycans. To accurately determine the kinetics of receptor egress from the ElL, bands corresponding to the mobility of glycosylated and nonglycosylated transferrin receptor (filled and unfilled arrowhead, respectively; , and separated by SDS-PAGE. The amount of class I associated with TAP.1 was both enhanced and prolonged in LLnL-treated cells (Fig. 3,  A-C) . This is most clearly seen at 240 min of chase, where almost undetectable levels of M H C class I molecules were TAP associated in control cells whereas clear bands were present in the LLnL-treated cells.
LLnL Affects Peptide Association with M H C Class I Molecules. To ascertain ifpeptide association with class I molecules was affected by treatment with LLnL, cells were metabolically labeled and the isolated peptides separated by lLP-HPLC. Fig. 4 , A and B depict peptides eluted from HLA-A2. The amount of stable HLA-A2 molecules recovered from cells treated with LLnL was decreased to less than half the amount recovered from control cells. As a resuit, the total yield of isolated peptides was reduced. The reduction in recovery was not a consequence of a reduction of overall labeling efficiency. LLnL had no effect on labeling efficiency under the conditions used. The population of peptides bound by HLA-A2 was also qualitatively different as evidenced by the general suppression of peaks with the exception of a single peak in fraction numbers 70-74 (Fig.  4 B) . The most dramatic effect on bound peptides was seen with HLA-B7 (Fig. 4, C and D) . In this example, equal numbers of cells were treated, and again, less than half the amount of class I molecules was recovered. Here the profiles were normalized to account for the difference in the amounts of recovered heavy chain and showed a striking enhancement of peaks in fractions 100 and 125 in the LLnL-treated population (note the change in the y-axis). A similar but less dramatic effect was seen for H L A -B 2 7 -bound peptides, also normalized for the amount o f recovered heavy chain (Fig. 4, E and F) . For HLA-B27, as in the previous examples, peaks at 75, 90, and 110 were enhanced. The augmentation o f a single peak in the presence of LLnL was also demonstrated with H L A -A 3 (data not shown). The peptides that are enhanced by LLnL may represent peptides translated at this length in the cytoplasm requiting no proteolytic cleavage, they may be peptides whose generation is unaffected by the inhibitory action of LLnL, or they may be signal sequence peptides generated in the Elk whose generation is also unaffected by LLnL. Both H L A -A 2 and HLA-B7 have been shown to bind signal sequence-derived peptides (5-7). To determine the origin of these peptides, it would be necessary to sequence them. Unfortunately, the time during which cells can be treated with LLnL is hmited to 10 h, after which they begin to die (data not shown). This would make it difficult to accumulate sufficient quantifies o f the peptides for sequencing.
LLnL Inhibits Peptide Generation in the ER. The prolonged
TAP association and slower transport o f M H C class I molecules in LLnL-treated cells was assumed to result from a reduction in the supply of cytosohcally generated peptides. HLA-A2 in .174 and T2 cells binds signal sequence peptides, and its transport should therefore not be affected by LLnL. U n e xpectedly, however, the rate o f egress o f H L A -A 2 from the EP, in .174 was found to be greatly diminished in the presence of the inhibitor (Fig. 5 A) . To determine if the inhibi-tion of signal sequence peptide generation was reducing H L A -A 2 assembly and transport, H P L C profiles of peptides bound by H L A -A 2 in .174, with and without LLnL treatment, were generated (Fig. 5 B) . The major doublet to be peptides derived from signal sequence peptides (5, 6) . The six signal sequence peptides isolated from H L A -A 2 in T2 were synthesized, and their retention times in lLP-H P L C were determined (Table 1) . These peptides included fragments of the signal sequences of calreticulin, the ~-interferon inducible protein (IP-30), and the signal sequence receptor ot subunit. The synthetic peptides coeluted with the peptides isolated from .174, although the requirement for collecting fractions to detect the 3H-labeled peaks made it impossible to resolve three of the peptides, which are grouped as peak 3 in Fig. 5 and Table 1 . However, only peaks 2 and 4 were unaffected by LLnL. Peak 2 corresponds to the longest peptide (12 residues) derived from IP-30 and terminates in a C O O H -t e r m i n a l glutamine residue. Peak 4 corresponds to a part of the calreticulin signal sequence and ends in glycine. Peak 1 and all the potential components o f peak 3 terminate in valine or alanine. Thus LLnL in this case may be inhibiting a peptidase with specificity for an aliphatic residue. Because signal sequences are cleaved in the ElL, and the TAP deficiency o f .174 precludes the reentry of peptides into the E R after cytosolic trimming, it seems most likely that the affected enzyme is an ElL peptidase.
Cytosolic and ER Proteolysis Have Distinct Sensitivities to LLnL and Z-LLF-CHO.
To determine the relative sensitivities of the proteases affecting class I assembly in CllL.A2 and .174 to LLnL and a more potent proteasome inhibitor (Z-LLF-C H O ; 20), we titrated their effects on the intracellular transport o f H L A -A 2 by pulse-chase analysis (Fig. 6 ). Inhibition of H L A -A 2 transport by LLnL and Z -L L F -C H O in C 1 R . A 2 was detectable at 2.0 and 0.08 IxM, respectively (Fig. 6, A and C) . However, in .174, 50.0 I-~M LLnL and 2.0 ~M Z -L L F -C H O were required for an observable effect (Fig. 6, B and D) . These findings are consistent with the idea that the responsible protease in C l l L and the responsible protease inhibited in .174 are different, and that the protease in CllL, presumably the proteasome, is significantly more sensitive. Z -L L F -C H O was also found to affect the peptide profile of C I k . B 7 in a similar fashion to LLnL (data not shown).
Discussion
Many studies have focused on the role o f the 26S protease complex (and its core subunit, the 20S proteasome) in Retention times and source ofHLA-A2-associated peptides in .174 (see Fig. 5 ). Indicated references are Wei and Cresswell (6) LLnL treatment produced all of the predicted effects on class I processing that would result from a peptide-deficient state in the cell. First, the rate at which class I molecules were transported from the ER was slowed in the presence of LLnL. Second, the association of class I and TAP molecules in the El< was enhanced and extended by treatment with LLnL. Third, the amount ofpeptides bound by class I molecules was decreased. LLnL caused a reversible accumulation of ubiquitinated proteins, normally degraded by the 26S protease complex, lkock et al. (16) showed that the ability of a range of peptide aldehyde inhibitors, including LLnL, to inhibit proteasome function, correlated with their ability to block MHC class I-restricted antigen processing. Thus, although the precise role ofubiquitination in antigen processing remains in question, the combination of evidence strongly argues that the proteasome is the major protease involved. In addition to reducing the overall yield of MHC class I molecules and associated peptides (Fig. 4, A and B) , LLnL also induced changes in the profile ofpeptides bound. This is particularly evident in Fig. 4 , C and D, where two HLA-B7-associated peaks are dramatically increased. These and similar peaks must correspond to peptides either unaffected by LLnL and better represented because of an overall reduction in the available competing pool of peptides, or to peptides actively enhanced by LLnL treatment. For example, polypeptides might normally be cleaved within the peptide sequences enhanced in LLnL-treated cells. This could occur either in the cytosol, perhaps mediated by the chymotryptic-like activity most strongly inhibited by LLnL (21), or even in the Elk after TAP-mediated translocation.
That peptide cleavage can occur in the El< is clearly shown by the effects of LLnL on the signal sequencederived peptides associated with HLA-A2 in the TAP-negative .174 cell line (Fig. 5) . LLnL treatment unexpectedly slowed the egress of HLA-A2 from the Elk in .174, as did a second inhibitor, Z-LLF-CHO (Fig. 6) . The inhibitors had no effect on the transport rate of transferrin receptors in .174 cells, arguing for an effect specific to class I molecules (data not shown). HLA-A2 escapes the El< in TAP-negative cell lines because it binds peptides generated from a number of hydrophobic signal sequences. We found that LLnL inhibited the generation of the majority of signal sequence-derived peptides that bind to the HLA-A2 allele and propose that the decrease in HLA-A2-specific peptides reduces the number of properly assembled, transport-competent HLA-A2 molecules. Effects on signal sequence degradation are unlikely to result from proteasome inhibition because the proteasome is confined to the cytosol and nucleus (33) . Although evidence exists for an ATP-dependent mechanism for peptide translocation from the Elk to the cytosol (34), any peptides trimmed in the cytosol presumably would require TAP to reenter the Elk. Thus, in. 174, any peptidase involved in generating class I-associated peptides and affected by LLnL must reside in the ER. The data shown in Fig. 5 B and Table 1 suggest that the peptidase inhibited by LLnL may cleave COOH-terminal to aliphatic amino acids because the unaffected peptides (peak 2 and 4, Fig. 5 B) terminate in a glutamate residue and glycine residue, respectively. However, with the limited number ofpeptides available for study it would be premature to make this a firm conclusion.
Transport of HLA-A2 molecules was found to be affected at lower concentrations of LLnL and Z-LLF-CHO in Cllk cells than in .174 cells (Fig. 6 ). Nevertheless, it seems likely that some of the effects of LLnL on class I peptide loading in wild-type cells could result from inhibition of Elk peptidases. When such inhibitors are used to investigate the origin of individual peptides that serve as T cell epitopes, as opposed to studies of the general process of MHC class I-restricted peptide generation, this possibihty clearly must be borne in mind. Trimming of certain peptides in the Elk, first suggested by Falk et al. (35) and for which reasonable evidence now exists (36, 37) , may be inhibited by LLnL or other peptide aldehyde inhibitors that also inhibit proteasome-mediated degradation. Even more specific proteasome inhibitors, such as the recently described Streptomyces-derivative lactacystin (38), must be evaluated for possible effects on Elk-mediated proteolysis before their use in antigen-processing studies can be properly evaluated. Clearly, inhibitors that specifically affect El< peptidases would be extremely useful in investigating the mechanisms involved in generating MHC class I-associated peptides. Effects on signal sequence degradation, measured using HLA-A2 in. 174 cells to "trap"the degradation intermediates as shown in Fig. 5 , might provide a useful assay for such inhibitors.
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